SCHEMBL29630634

SCHEMBL29630634

C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NOD1 Q9Y239 1/20 0.52
BMP1 P13497 1/20 0.41
KMT2A Q03164 2/20 0.41
BACE1 P56817 7/20 0.41
FOLH1 Q04609 4/20 0.40
DPP4 P27487 1/20 0.40
DPP8 Q6V1X1 1/20 0.40
DPP9 Q86TI2 1/20 0.40
ALOX15 P16050 1/20 0.40
BLM P54132 1/20 0.40
PMP22 Q01453 1/20 0.40
CA2 P00918 2/20 0.39
CA1 P00915 1/20 0.39
ECE1 P42892 1/20 0.38
RIMKLA Q8IXN7 1/20 0.38
NAALAD2 Q9Y3Q0 1/20 0.38
CTSD P07339 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4281665 0.97 NOD1 (0.54) NOD1BMP1KMT2ABACE1FOLH1
SCHEMBL31376473 0.97 NOD1 (0.54) NOD1BMP1KMT2ABACE1FOLH1
SCHEMBL31026348 0.97 NOD1 (0.54) NOD1BMP1KMT2ABACE1FOLH1
SCHEMBL31026347 0.97 NOD1 (0.54) NOD1BMP1KMT2ABACE1FOLH1
SCHEMBL31376470 0.97 NOD1 (0.54) NOD1BMP1KMT2ABACE1FOLH1
SCHEMBL31376471 0.97 NOD1 (0.54) NOD1BMP1KMT2ABACE1FOLH1
SCHEMBL16672263 0.97 NOD1 (0.54) NOD1BMP1KMT2ABACE1FOLH1
SCHEMBL1692049 0.97 NOD1 (0.54) NOD1BMP1KMT2ABACE1FOLH1
SCHEMBL29022777 0.96 NOD1 (0.49) NOD1BMP1BACE1FOLH1RIMKLA
SCHEMBL29022775 0.96 NOD1 (0.49) NOD1BMP1BACE1FOLH1RIMKLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023160499-A1 PEPTIDE, OPHTHALMIC PHARMACEUTICAL COMPOSITION CONTAINING SAME AND USE THEREOF 盛元医药广州有限公司 2023-08-31 WO claimed
US-11807899-B2 Biochemical reaction methods and reagents comprising intrinsically disordered regions Biocrucible Limited 2023-11-07 US disclosed
WO-2023160499-A1 PEPTIDE, OPHTHALMIC PHARMACEUTICAL COMPOSITION CONTAINING SAME AND USE THEREOF 盛元医药广州有限公司 2023-08-31 WO disclosed
US-20220145378-A1 BIOCHEMICAL REACTION METHODS AND REAGENTS COMPRISING INTRINSICALLY DISORDERED REGIONS Biocrucible Limited (GB) 2022-05-12 US disclosed